Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk

BACKGROUND: Response to modern treatment strategies, which combine cytotoxic compounds with immune stimulatory agents and targeted treatment is highly variable among MCL patients. Thus, providing prognostic and predictive markers for risk adapted therapy is warranted and molecular information that c...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMC Cancer
Hoofdauteurs: Lokhande, Lavanya, Kuci Emruli, Venera, Kolstad, Arne, Hutchings, Martin, Räty, Riikka, Jerkeman, Mats, Ek, Sara
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2020
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7720632/
https://ncbi.nlm.nih.gov/pubmed/33287742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07678-4
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items